Clinical Trial Update: LEE011 Plus Everolimus in Patients With Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the combination of LEE011 (ribociclib) and everolimus in patients with metastatic pancreatic adenocarcinoma refractory to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Everolimus (everolimus)
• LEE011 (ribociclib)

Snippet

Sponsor: Georgetown University | Conditions: Metastatic Pancreatic Adenocarcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-04-07